37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cross-centre replication of suppressed burrowing behaviour as an ethologically relevant pain outcome measure in the rat: a prospective multicentre study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Supplemental Digital Content is Available in the Text.

          This unique multicenter approach provides high-quality evidence validating burrowing as a robust and reproducible outcome measure to infer the global effect of pain on rodents.

          Abstract

          Burrowing, an ethologically relevant rodent behaviour, has been proposed as a novel outcome measure to assess the global impact of pain in rats. In a prospective multicentre study using male rats (Wistar, Sprague-Dawley), replication of suppressed burrowing behaviour in the complete Freund adjuvant (CFA)-induced model of inflammatory pain (unilateral, 1 mg/mL in 100 µL) was evaluated in 11 studies across 8 centres. Following a standard protocol, data from participating centres were collected centrally and analysed with a restricted maximum likelihood-based mixed model for repeated measures. The total population (TP—all animals allocated to treatment; n = 249) and a selected population (SP—TP animals burrowing over 500 g at baseline; n = 200) were analysed separately, assessing the effect of excluding “poor” burrowers. Mean baseline burrowing across studies was 1113 g (95% confidence interval: 1041-1185 g) for TP and 1329 g (1271-1387 g) for SP. Burrowing was significantly suppressed in the majority of studies 24 hours (7 studies/population) and 48 hours (7 TP, 6 SP) after CFA injections. Across all centres, significantly suppressed burrowing peaked 24 hours after CFA injections, with a burrowing deficit of −374 g (−479 to −269 g) for TP and −498 g (−609 to −386 g) for SP. This unique multicentre approach first provided high-quality evidence evaluating suppressed burrowing as robust and reproducible, supporting its use as tool to infer the global effect of pain on rodents. Second, our approach provided important informative value for the use of multicentre studies in the future.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: not found
          • Article: not found

          Ethical guidelines for investigations of experimental pain in conscious animals.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Different immune cells mediate mechanical pain hypersensitivity in male and female mice.

            A large and rapidly increasing body of evidence indicates that microglia-to-neuron signaling is essential for chronic pain hypersensitivity. Using multiple approaches, we found that microglia are not required for mechanical pain hypersensitivity in female mice; female mice achieved similar levels of pain hypersensitivity using adaptive immune cells, likely T lymphocytes. This sexual dimorphism suggests that male mice cannot be used as proxies for females in pain research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A call for transparent reporting to optimize the predictive value of preclinical research.

              The US National Institute of Neurological Disorders and Stroke convened major stakeholders in June 2012 to discuss how to improve the methodological reporting of animal studies in grant applications and publications. The main workshop recommendation is that at a minimum studies should report on sample-size estimation, whether and how animals were randomized, whether investigators were blind to the treatment, and the handling of data. We recognize that achieving a meaningful improvement in the quality of reporting will require a concerted effort by investigators, reviewers, funding agencies and journal editors. Requiring better reporting of animal studies will raise awareness of the importance of rigorous study design to accelerate scientific progress.
                Bookmark

                Author and article information

                Journal
                Pain
                Pain
                JPAIN
                Pain
                JOP
                Pain
                Wolters Kluwer (Philadelphia, PA )
                0304-3959
                1872-6623
                October 2016
                16 September 2016
                : 157
                : 10
                : 2350-2365
                Affiliations
                [a ]Pain Research Group, Department of Surgery and Cancer, Imperial College, London, United Kingdom
                [b ]Eli Lilly and Company, Erl Wood Manor, Windlesham, United Kingdom
                [c ]Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden
                [d ]Neuroscience CNSP iMED, AstraZeneca R&D Södertälje, Södertälje, Sweden
                [e ]Department of Neurobiology, Boston Children's Hospital, MA, USA
                [f ]Danish Pain Research Center, Aarhus University Hospital, Aarhus, Denmark
                [g ]CNS Disease Division Research Germany, Boehringer Ingelheim Pharma GmbH and Co KG, Biberach an der Riss, Germany
                [h ]Department of Neurophysiology, Centre for Biomedicine and Medical Technology Mannheim (CBTM), Heidelberg University, Mannheim, Germany
                [i ]Department of Pharmacology and Biomarker Development, Translational Science and Strategy, Grünenthal GmbH, Aachen, Germany
                [j ]Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom
                [k ]Eli Lilly and Company, Indianapolis, IN, USA
                [l ]Laboratory for Pharmacology, Pharmaceutical Research Center, Asahi Kasei Pharma Corporation, Shizuoka, Japan
                [m ]H. Lundbeck A/S, Valby, Denmark
                [n ]Deal, Kent, United Kingdom. L. A. Bryden is now with the Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom. W. Huang is now with the Institute of Medical Sciences, University of Aberdeen, United Kingdom. C. Stenfors is now with the R&D CNS Research, Orion Corporation, Orion Pharma, Espoo, Finland.
                Author notes
                [* ]Corresponding author. Address: Department of Pharmacology and Biomarker Development, Translational Science and Strategy, Grünenthal GmbH, 52078 Aachen, Germany. Tel.: +49-241-569-2077; fax: +49-241-569-2852. E-mail address: kris.rutten@ 123456grunenthal.com (K. Rutten).
                Article
                PAIN-D-14-14664 00024
                10.1097/j.pain.0000000000000657
                5028161
                27643836
                691f4509-9f07-4108-93bc-ad7a356f33c5
                © 2016 International Association for the Study of Pain

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

                History
                : 11 January 2016
                : 19 May 2016
                : 20 May 2016
                Categories
                Research Paper
                Custom metadata
                TRUE
                T

                Anesthesiology & Pain management
                non-evoked pain,validation,reproducibility,preclinical controlled trials

                Comments

                Comment on this article